Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from ABx Group Limited ( (AU:ABX) ).
ABx Group’s ALCORE subsidiary has submitted an Environmental Effects Report for its planned hydrogen fluoride pilot plant in Bell Bay, Tasmania, marking a key step in the environmental approvals process. The report outlines comprehensive controls for solid, liquid and gaseous streams, emissions, noise and site management, signalling that environmental considerations are embedded in the plant’s design and operating plans.
Progress on the pilot facility is advancing, with civil design complete, a building permit lodged, and a site power upgrade scoped and scheduled. Equipment deliveries are set to begin in April ahead of construction and commissioning in 2026, while the appointment of two Senior Process Engineers and collaboration with specialist firms Kempe Engineering and BFluor Chemicals underscore ABx’s confidence in the ALCORE technology and its move from design to construction.
The most recent analyst rating on (AU:ABX) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on ABx Group Limited stock, see the AU:ABX Stock Forecast page.
More about ABx Group Limited
ABx Group Limited is an Australian resources and technology company focused on developing advanced materials and chemical processes through its majority-owned subsidiary ALCORE. The group is working to commercialise hydrogen fluoride production technology at its ALCORE Technology Centre in Bell Bay, Tasmania, targeting applications across the fluorochemical value chain.
Average Trading Volume: 2,331,592
Technical Sentiment Signal: Hold
Current Market Cap: A$25.82M
For a thorough assessment of ABX stock, go to TipRanks’ Stock Analysis page.